Research on CBD for Alzheimer's & Dementia

| in Dementia, Research |

Preliminary research is showing that there may be some positive effects for the treatment of Alzheimer's and dementia using the phytocannabinoid CBD.  Every human is pre-wired to be responsive to cannabinoids through receptors in the Endocannabinoid System.

1- Endocannabinoid signalling in Alzheimer’s disease

2- A molecular link between the active component of marijuana and Alzheimer’s disease pathology

3- Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells

4- The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease

5- Cannabinoids for the treatment of dementia

6- Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

7- Cannabidiol: A promising drug for neurodegenerative disorders?

8- Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition

9- The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses

10- The role of phytochemicals in the treatment and prevention of dementia

11- Cannabinoids for the treatment of dementia

12- Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement

13- Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic